Acute Hepatitis C Virus Infection: a Chronic Problem

Overview

Journal Hepatology

Specialty Gastroenterology

Date 2007 Dec 29

PMID 18161707

Citations 35

Authors

Jason T Blackard

M Tarek Shata

Norah J Shire

Kenneth E Sherman

Affiliations

Soon will be listed here.

Citing Articles

Antiviral potential of ginseng: Targeting human pathogenic viruses with compounds derived from ginseng.

Huo C, Baek J, Kim K J Ginseng Res. 2025; 49(2):105-117.

PMID: 40061485 PMC: 11889387. DOI: 10.1016/j.jgr.2024.12.004.

Prevalence, diagnosis, treatment, and associated factors of hepatitis C in the United States from 1999 to 2018: A population-based cross-sectional study.

Zhang C, Lu J, Zhang Y, He P, Xia J, Huang M Liver Res. 2025; 6(4):284-288.

PMID: 39957907 PMC: 11791864. DOI: 10.1016/j.livres.2022.12.003.

Dysregulation in the microbiota by HBV and HCV infection induces an altered cytokine profile in the pathobiome of infection.

Padilha M, Melo F, Laurentino R, da Silva A, Feitosa R Braz J Infect Dis. 2024; 29(1):104468.

PMID: 39608222 PMC: 11636304. DOI: 10.1016/j.bjid.2024.104468.

Biomarkers in Detection of Hepatitis C Virus Infection.

Woo J, Choi Y Pathogens. 2024; 13(4).

PMID: 38668286 PMC: 11054098. DOI: 10.3390/pathogens13040331.

Evaluation of Two-Assay Serological Testing Strategies for Anti-HCV Screening in Italian Populations: A Dual Screening Approach.

Zocca E, Seraceni S, Cafaro T, Cervone T, Cardarelli L, Valisi M Diagnostics (Basel). 2024; 14(6).

PMID: 38534991 PMC: 10969070. DOI: 10.3390/diagnostics14060570.

References

Luetkemeyer A, Hare C, Stansell J, Tien P, Charlesbois E, Lum P . Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr. 2005; 41(1):31-6. PMC: 4050666. DOI: 10.1097/01.qai.0000191281.77954.27. View

Wiegand J, Buggisch P, Boecher W, Zeuzem S, Gelbmann C, Berg T . Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology. 2006; 43(2):250-6. DOI: 10.1002/hep.21043. View

Armstrong G, Williams I, Maga U, Viali S, Kuhnert W, McGarvey S . Hepatitis C virus infection in Samoa and American Samoa. Am J Trop Med Hyg. 2006; 74(2):261-2. View

Serpaggi J, Chaix M, Batisse D, Dupont C, Vallet-Pichard A, Fontaine H . Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy. AIDS. 2006; 20(2):233-40. DOI: 10.1097/01.aids.0000200541.40633.56. View

Morishima C, Polyak S, Ray R, Doherty M, Di Bisceglie A, Malet P . Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C. J Infect Dis. 2006; 193(7):931-40. DOI: 10.1086/500952. View

Kamal S, Fouly A, Kamel R, Hockenjos B, Al Tawil A, Khalifa K . Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. Gastroenterology. 2006; 130(3):632-8. DOI: 10.1053/j.gastro.2006.01.034. View

Khakoo S, Thio C, Martin M, Brooks C, Gao X, Astemborski J . HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 2004; 305(5685):872-4. DOI: 10.1126/science.1097670. View

Freeman A, Ffrench R, Post J, Harvey C, Gilmour S, White P . Prevalence of production of virus-specific interferon-gamma among seronegative hepatitis C-resistant subjects reporting injection drug use. J Infect Dis. 2004; 190(6):1093-7. DOI: 10.1086/422605. View

Gale Jr M, Kwieciszewski B, Dossett M, Nakao H, Katze M . Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol. 1999; 73(8):6506-16. PMC: 112733. DOI: 10.1128/JVI.73.8.6506-6516.1999. View

10.

Semmo N, Barnes E, Taylor C, Kurtz J, Harcourt G, Smith N . T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet. 2005; 365(9456):327-9. DOI: 10.1016/S0140-6736(05)17787-3. View

11.

Sherman K, Shire N, Rouster S, Peters M, Koziel M, Chung R . Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology. 2005; 128(2):313-27. PMC: 4036101. DOI: 10.1053/j.gastro.2004.11.059. View

12.

Sumpter Jr R, Loo Y, Foy E, Li K, Yoneyama M, Fujita T . Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol. 2005; 79(5):2689-99. PMC: 548482. DOI: 10.1128/JVI.79.5.2689-2699.2005. View

13.

Chambers T, Fan X, Droll D, Hembrador E, Slater T, Nickells M . Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection. J Virol. 2005; 79(5):3071-83. PMC: 548442. DOI: 10.1128/JVI.79.5.3071-3083.2005. View

14.

Vogel M, Bieniek B, Jessen H, Schewe C, Hoffmann C, Baumgarten A . Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases. J Viral Hepat. 2005; 12(2):207-11. DOI: 10.1111/j.1365-2893.2005.00580.x. View

15.

Cox A, Netski D, Mosbruger T, Sherman S, Strathdee S, Ompad D . Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis. 2005; 40(7):951-8. DOI: 10.1086/428578. View

16.

Li K, Chen Z, Kato N, Gale Jr M, Lemon S . Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem. 2005; 280(17):16739-47. DOI: 10.1074/jbc.M414139200. View

17.

Fuller M, Hildeman D, Sabbaj S, Gaddis D, Tebo A, Shang L . Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help. J Immunol. 2005; 174(10):5926-30. DOI: 10.4049/jimmunol.174.10.5926. View

18.

Cox A, Mosbruger T, Mao Q, Liu Z, Wang X, Yang H . Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med. 2005; 201(11):1741-52. PMC: 2213263. DOI: 10.1084/jem.20050121. View

19.

Bartosch B, Verney G, Dreux M, Donot P, Morice Y, Penin F . An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol. 2005; 79(13):8217-29. PMC: 1143705. DOI: 10.1128/JVI.79.13.8217-8229.2005. View

20.

Rauch A, Rickenbach M, Weber R, Hirschel B, Tarr P, Bucher H . Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clin Infect Dis. 2005; 41(3):395-402. DOI: 10.1086/431486. View